Distribution of a second vaccine against the coronavirus can begin in the United States. The FDA has given the vaccine from the pharmaceutical company Moderna emergency approval. The European Medicines Agency does not want to make its recommendation until the new year. The US Food and Drug Administration (FDA) has granted emergency approval to the corona vaccine from the domestic pharmaceutical company Moderna. The FDA announced this early in the morning German time on Twitter. The agency’s independent advisory committee had already spoken out in favor of this the day before. About a week ago, the vaccine from the Mainz biotech company Biontech and its US partner Pfizer also received emergency approval. It has been used in the USA since Monday, but it has to be cooled more elaborately than the Moderna preparation. US government officials had said in the previous days that the drug could begin to be used at the beginning of next week. They expect that almost six million vaccine doses will be available for distribution immediately after approval. “Congratulations, the Moderna vaccine is now available,” tweeted US President Donald Trump minutes after the FDA made the statement. However, experts had repeatedly stated that those in particular need of protection first received the vaccination and it could take months before enough funds were available for the general population.
EU has ordered 160 million cans

It is the first approval worldwide for the Moderna active ingredient. Based in Cambridge, Massachusetts, the company expects 20 million doses of the vaccine called mRNA-1273 to be available in the US by the end of the year. Production of 100 to 125 million vaccine doses is expected for the first three months of the coming year. Of these, 15 to 25 million should be available outside the US. Overall, the group expects to be able to manufacture up to a billion vaccine doses worldwide in 2021. In order to have full immune protection, each vaccinated person must receive two doses.

“Medical miracle” Pelosi and Pence get vaccinated

The EU Commission has ordered a total of 160 million vaccine doses from Moderna. The first deliveries are expected to arrive in early 2021, provided the European Medicines Agency approves the vaccine. Ema announced on Thursday that it would make a recommendation on January 6th. Moderna announced at the end of November based on its pivotal Phase III study that its vaccine was 94.1 percent effective. According to a publication in the “New England Journal of Medicine” (“NEJM”), data from a so-called Phase I study also showed that the immune response triggered by the vaccine was clearly detectable in the blood for several months. The result could indicate that the Moderna vaccination offers protection against Covid-19 for a longer period of time. But that is not proof.

Tags: suchen suche search tag anzeigen besucherzahl browser design domain inhalt jahr karpfen konto problem inhalt schalten modellbahn spielemax spiel tag webseite preise werbung

Reichsmarschall Göring hatte eine Märklin Modelleisenbahn >>> read more